[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100621048":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":33,"centralContacts":37,"locations":43,"responsibleParty":62,"collaborators":30,"id":65,"slug":30,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":69,"acronym":70,"eligibilityCriteria":71,"healthyVolunteers":66,"sex":72,"minAge":73,"maxAge":74,"enrollmentInfo":75,"targetDuration":30,"studyType":78,"phases":79,"briefSummary":81,"conditions":82,"keywords":84,"overallStatus":46,"whyStopped":30,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":97},{"fullName":5,"class":6},"China Medical University Hospital","OTHER",[8,14,20],{"label":9,"type":10,"description":11,"interventionNames":12},"Omega-3 (EPA)","EXPERIMENTAL","EPA",[13],"Dietary Supplement: Omega-3",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo","PLACEBO_COMPARATOR","Soybean Oil",[19],"Dietary Supplement: Placebo",{"label":21,"type":10,"description":22,"interventionNames":23},"Omega-3 (DHA)","DHA",[13],[25,31],{"type":26,"name":27,"description":28,"armGroupLabels":29,"otherNames":30},"DIETARY_SUPPLEMENT","Omega-3","Omega-3 PUFAs",[21,9],null,{"type":26,"name":15,"description":17,"armGroupLabels":32,"otherNames":30},[15],[34],{"name":35,"affiliation":5,"role":36},"Pei-Chen Chang, MD, PhD","PRINCIPAL_INVESTIGATOR",[38],{"name":35,"role":39,"phone":40,"phoneExt":41,"email":42},"CONTACT","0422052121","4126","d13121@mail.cmuh.org.tw",[44],{"facility":45,"status":46,"city":47,"state":47,"zip":48,"country":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"China Medical University","RECRUITING","Taichung","404","Taiwan",{"type":51,"coordinates":52},"Point",[53,54],120.6839,24.1469,{"lat":54,"lon":53},[57,61],{"name":58,"role":39,"phone":59,"phoneExt":30,"email":60},"Pei-Chen Chang, MD, PHD","886 4 22052121","013121@tool.caaumed.org.tw",{"name":35,"role":36,"phone":30,"phoneExt":30,"email":30},{"type":36,"investigatorFullName":63,"investigatorTitle":64,"investigatorAffiliation":5,"oldNameTitle":30,"oldOrganization":30},"Pei-Chen Chang","PI","100621048",false,"NCT07365553","Omega-3, Autism Spectrum Disorder (ASD)","Omega-3 Fatty Acids and Autism Spectrum Disorder (ASD) - A Double-blind Randomized Controlled Trial of Omega-3 Fatty Acids in Youth With ASD","OMeASD","Inclusion Criteria:\n\n* diagnosis of DSM5 ASD made by child and adolescent psychiatrist\n* age 6-17 years-old at the time of enrolment\n* no pharmacotherapy or non-pharmacotherapy adjustment within the past 4 weeks,\n* Signed informed consent.\n\nExclusion Criteria:\n\n* comorbid other psychiatric disorders, including schizophrenia or affective mood disorder (Bipolar and Major Depressive Disorder), or substance use disorder\n* comorbid physical disorders, such as thyroid dysfunction, cerebral palsy, coagulation disorders\n* currently using omega-3 supplements or probiotics\n* allergy to omega-3.","ALL","6 Years","17 Years",{"count":76,"type":77},50,"ESTIMATED","INTERVENTIONAL",[80],"NA","This is a 12 week study to investigate the effects of omega-3 polyunsaturated fatty acids (PUFAs) in youth with autism spectrum disorder (ASD).",[83],"ASD",[85,86,87],"inflammation","adolescent","omega-3","2026-01-16",{"date":90,"type":91},"2026-01-26","ACTUAL",{"date":93,"type":91},"2022-07-15",{"date":95,"type":77},"2026-07-31",{"name":5,"class":6},1]